left-caret

NEWS

폴 헤이스팅스, 에스디바이오센서와 SJL파트너스의 미화 15억 3천만 달러 규모 메리디안 바이오사이언스 인수 자문

July 07, 2022

New York and Seoul – Paul Hastings LLP, a leading global law firm, announced today that the firm advised SD Biosensor and SJL Partners on a definitive merger agreement to acquire Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials. Under the terms of the agreement, a newly formed affiliate of the consortium of SD Biosensor and SJL Partners will acquire Meridian in an all-cash transaction valued at approximately $1.53 billion.

The transaction is expected to close in the fourth quarter of 2022, subject to approval by Meridian shareholders, receipt of required regulatory approvals, the absence of specified materially adverse outcomes of Meridian's previously disclosed and ongoing investigation by the U.S. Department of Justice, and other customary closing conditions.

Corporate partners Robert Leung and Iksoo Kim led the Paul Hastings team, which also included partner Dong Chul Kim and associates Vinnie Buehler, Anna Hardcastle, and Celina Hong.

Additional advice was provided by partners Nathan Sheers, Peter Lindsay, and Charles Patricia, of counsel Jennifer Riddle and associate Jesselyn Pe (Regulatory and Enforcement); partners Michael Wise and Camille Paulhac, and associates Juliette Hua, and Mary Walser (Antitrust); partner Michael Haun and of counsel Amy Lawrence (Tax); partner Eric Keller and associate Bill McCue (Employee Benefits); partner Todd Schneider and associates Laura Yip and April White (IP); partner Holly Snow and associate Gabriella Pan (Finance); partners Bradley Ritter and Thomas Mounteer (Real Estate); associates David Coogan and Veronica Canton (Privacy and Data Security); of counsel Randall Johnston, and associates Talya Hutchison, Ryan Poitras, and Rachel Miller (Global Trade Controls).

 

About Paul Hastings

Dedicated to providing intellectual capital and superior execution to the world’s leading Wall Street and global investment banks, asset managers and corporations, Paul Hastings is a premier global finance law firm with elite teams in finance, mergers and acquisitions, private equity and litigation. It is one of only a handful of law firms ranked across multiple core finance areas including: structured credit, leveraged finance, private credit, capital markets, and real estate finance.

Paul Hastings is ranked as one of the top firms in the world in The American Lawyer’s “Premier League” for momentum, profit and prestige amongst firms in the 2022 American Lawyer 100.

Practice Areas

Korea

Life Sciences and Healthcare

Corporate

Mergers and Acquisitions


SIGN UP FOR NEWS INSIGHTS

MEDIA CONTACTS

Submission Requests

저희에게 연락해주세요

문의하기